LONDON--(EON: Enhanced Online News)--Technavio has published three reports, including cystic fibrosis therapeutics, RFID blood monitoring systems, and hemophilia drugs, categorized under the healthcare and life sciences sector. The reports highlight the major market trends, drivers, challenges and several other factors that are expected to change market dynamics during the forecast period.
Buy these reports and get USD 1200 worth of free additional custom research information on any report.
Global Cystic Fibrosis Therapeutics Market 2016-2020
Request a sample report: http://www.technavio.com/request-a-sample?report=53892
The global cystic fibrosis therapeutics market is expected to witness tremendous growth and will post a CAGR of close to 32% over the forecast period. One of the major factors driving this market’s growth is the drastic improvement in diagnostic techniques around the world. Cystic fibrosis is a genetically inherited disease and has a multitude of screening tests that helps in its detection. Some of the most popular methods of diagnosis are carrier testing, antenatal testing, newborn screening, and other tests like genetic and sweat tests. An increase in research and development activities has led to the development of novel diagnostic tools for cystic fibrosis.
Global RFID Blood Monitoring Systems Market 2016-2020
Request a sample report: http://www.technavio.com/request-a-sample?report=51949
Technavio;s research analysts have projected that the global RFID blood monitoring systems market will show an impressive growth during the predicted period and post a CAGR of close to 23% by 2020. RFIDs are gradually replacing the use of 1D and 2D barcodes. Barcodes work only when the scanner is placed directly in front of the label and do not offer durability. Whereas, RFID uses radio waves to communicate and does not require proper orientation of label and scanner. RFID tags are only required to be within the reading range of the reader, which will drive the efficiency of logistics in various applications including blood transfusions.
Global Hemophilia Drugs Market 2016-2020
Request a sample report: http://www.technavio.com/request-a-sample?report=53301
Extensive research carried out by the analysts at Technavio has shown that the global hemophilia drugs market will witness steady growth and will post a moderate CAGR of more than 5% over the forecast period. With increasing focus on prophylactic treatment, the market for hemophilia drugs is expected to have a positive outlook over the coming years. The prophylactic treatment approach prevents spontaneous bleeding episodes, significantly improves the quality of life in terms of physical activities, and maintains the level of clotting factors above a baseline. The study conducted by the US National Library of Medicine determined that the savings on prophylactic treatment be approximately USD 8,312 to USD 17,675 per bleeding episode in a person.
Browse Related Reports:
- Global Idiopathic Pulmonary Fibrosis Market 2016-2020
- Global Genetic Testing Market 2015-2019
- Cystic Fibrosis Market in Europe 2015-2019
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cardiovascular devices, central nervous system, and in-vitro diagnostics. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.